SleepWeaver 3D Nasal Mask

K162905 · Circadiance, LLC · BZD · Mar 15, 2017 · Anesthesiology

Device Facts

Record IDK162905
Device NameSleepWeaver 3D Nasal Mask
ApplicantCircadiance, LLC
Product CodeBZD · Anesthesiology
Decision DateMar 15, 2017
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 868.5905
Device ClassClass 2
AttributesTherapeutic, Pediatric

Intended Use

The SleepWeaver 3D Nasal Mask is intended to provide an interface for Continuous Positive Airway Pressure (CPAP) or Bi-Level therapy. This mask is intended for single-patient reuse in the home and single-patient reuse in the hospital / institutional environment. This mask is to be used on patients greater than 66 lbs (30 kg).

Device Story

Nasal mask interface for CPAP/Bi-Level therapy; delivers pressurized air to patient airway. Consists of elastic polyester fabric cushion, 4-point adjustable elastic fabric headgear with integrated plastic component, and 22mm L-shaped swivel connector. Used in home or hospital settings by patients > 66 lbs. Fabric cushion creates seal against nose via positive pressure; headgear secures mask. Swivel connector allows 360-degree rotation for tubing compatibility. Device is non-sterile, single-patient reuse; hand-washable. Benefits include comfortable, fabric-based interface for respiratory therapy.

Clinical Evidence

No clinical data. Substantial equivalence demonstrated via bench testing, including leak rate, pressure drop, CO2 rebreathing, sound pressure, and reliability (90 wash cycles) per ISO 17510:2015, and biocompatibility testing per ISO 10993.

Technological Characteristics

Materials: elastic polyester fabric, polycarbonate connector. Sensing/Actuation: passive interface for positive airway pressure (4-20 cmH2O). Form factor: nasal mask with 4-point adjustable headgear. Connectivity: standard 22mm tubing. Sterilization: non-sterile. Standards: ISO 17510:2015, ISO 14971:2007, ISO 10993-1/5/10.

Indications for Use

Indicated for patients > 66 lbs (30 kg) requiring CPAP or Bi-Level therapy for sleep apnea. No contraindications.

Regulatory Classification

Identification

A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes entwined around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus symbol. The logo is black and white. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 March 15, 2017 Circadiance, LLC James Gianoutsos Manager of Quality Assurance & Regulatory Affairs 1300 Rodi Rd Turtle Creek, Pennsylvania 15145 Re: K162905 Trade/Device Name: Sleepweaver 3D Nasal Mask Regulation Number: 21 CFR 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: Class II Product Code: BZD Dated: February 8, 2017 Received: February 9, 2017 Dear James Gianoutsos: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801): medical device reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely, Image /page/1/Picture/8 description: The image contains a signature and the name "Tina Kiang". Below the name, there is a "-s" present. The signature is complex and illegible. The background of the image has a light blue watermark. Tina Kiang, Ph.D. Acting Director Division of Anesthesiology. General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ SleepWeaver 3D Nasal Mask Models | Part Number | Description | Color | Size | |-------------|----------------------------------------------------|-------------------------------|---------------------------------| | 101496 | SleepWeaver 3D Nasal Mask Only, Blue | Blue | N/A* | | 101516 | SleepWeaver 3D Regular Headgear Only | Black | Regular | | 101517 | SleepWeaver 3D Large Headgear Only | Black | Large | | 101486 | SleepWeaver 3D Nasal Mask & Regular Headgear, Blue | Mask: Blue<br>Headgear: Black | Mask: N/A*<br>Headgear: Regular | | 101491 | SleepWeaver 3D Nasal Mask & Large Headgear, Blue | Mask: Blue<br>Headgear: Black | Mask: N/A*<br>Headgear: Large | {3}------------------------------------------------ # Indications for Use 510(k) Number (if known) K162905 Device Name SleepWeaver 3D Nasal Mask #### Indications for Use (Describe) The SleepWeaver 3D Nasal Mask is intended to provide an interface for Continuous Positive Airway Pressure (CPAP) or Bi-Level therapy. This mask is intended for single-patient reuse in the home and single-patient reuse in the hospital / institutional environment. This mask is to be used on patients greater than 66 lbs (30 kg). Type of Use (Select one or both, as applicable) | <span style="font-size:100%;">☑ Prescription Use (Part 21 CFR 801 Subpart D)</span> | <span style="font-size:100%;">☐ Over-The-Counter Use (21 CFR 801 Subpart C)</span> | |-------------------------------------------------------------------------------------|------------------------------------------------------------------------------------| |-------------------------------------------------------------------------------------|------------------------------------------------------------------------------------| #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {4}------------------------------------------------ ### 510(k) Summary #### (as per 21 CFR 807.92) #### SUBMITTER . Circadiance, LLC 1300 Rodi Road Turtle Creek, PA 15145 Phone: (724) 858-2837 Facsimile: (412) 202-4583 Contact Person: James Gianoutsos Title: Manager of Quality Assurance & Regulatory Affairs Date Prepared: October 14, 2016 #### II. SUBJECT DEVICE Name of Device: SleepWeaver 3D Nasal Mask Common or Usual Name: Nasal Mask Classification Name: Noncontinuous Ventilator (IPPB) (21 CFR 868.5905) Review Panel: Anesthesiology Regulatory Class: II Product Code: BZD Prior Submissions: None #### III. PREDICATE DEVICE SleepWeaver élan Nasal CPAP Mask, K120757 510(k) Holder: Circadiance, LLC This predicate has not been subject to a design-related recall No reference devices were used in this submission. ### IV. DEVICE DESCRIPTION The SleepWeaver 3D Nasal Mask consists of a fabric cushion, headgear, and a swivel connector. The device is to be used as an interface for Continuous Positive Airway Pressure (CPAP) or Bi-Level therapy. The mask consists of an elastic polyester fabric that provides a seal around the user's nose once positive airway pressure therapy is applied. The mask is held in place with a 4-point adjustable elastic fabric headgear that contains an integrated plastic component to direct the headgear away from the patient's ears. The headgear is attached through slots in the fabric mask to support the mask fit. The mask and headgear are designed to be hand washed in the home (single patient reuse) and the hospital / institutional environment (single patient reuse). Attached to the cushion is an L-shaped swivel connector that can rotate 360 degrees and is compatible with the industry standard 22mm air tubing. {5}------------------------------------------------ Associated accessories include: (Previously cleared under K120757 and have not been modified) - Feather Weight Tube . - . Tether Strap ## V. INDICATIONS FOR USE The SleepWeaver 3D Nasal Mask is intended to provide an interface for Continuous Positive Airway Pressure (CPAP) or Bi-Level therapy. This mask is intended for single-patient reuse in the home and single-patient reuse in the hospital / institutional environment. This mask is to be used on patients greater than 66lbs (30 kg). The Indications for Use statement for the SleepWeaver 3D Nasal Mask device is not identical to the predicate device; however, the differences do not alter the intended use of the device as both the subject and predicate devices have the same intended use for providing an interface for Continuous Positive Airway Pressure (CPAP) or Bi-Level therapy for the home and hospital / institutional environment. ## VI. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICE The SleepWeaver 3D Nasal Mask has the following similarities to the previously cleared predicate device, the SleepWeaver élan Nasal CPAP (K120757): - . Substantially equivalent intended use - . Same operating principle - . Similar mask and headgear design - Similar materials that have passed biocompatibility testing - . Same patient population for patients greater than 66 lbs (30 kg) The SleepWeaver 3D Nasal Mask has the following differences to the previously cleared predicate device, the SleepWeaver élan Nasal CPAP (K120757): - . The nasal interface material and geometry was changed compared to the predicate device. - . Headgear geometry was changed and includes an integrated plastic component that positions the lower straps below the patient's ears. - . Headgear is provided in two (2) sizes compared to the predicate which only had one (1) size. Table 1 details a side-by-side comparison of similarities and differences of the SleepWeaver 3D Nasal Mask to the previously cleared predicate device, the SleepWeaver élan Nasal CPAP (K120757) {6}------------------------------------------------ | Feature | Predicate Device:<br>SleepWeaver élan (K120757) | Subject Device:<br>SleepWeaver 3D Nasal Mask | Comments | |------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Intended Use | The SleepWeaver élan Nasal<br>CPAP Mask is intended to provide<br>an interface for Continuous<br>Positive Airway Pressure (CPAP)<br>or Bi-Level therapy. The<br>SleepWeaver élan Nasal CPAP<br>Mask is intended for single-patient<br>reuse in the home and multi-<br>patient, multi-use in the<br>hospital/institutional environment.<br>This mask is to be used on<br>patients greater than 66 lbs (30<br>kg). | The SleepWeaver 3D Nasal<br>Mask is intended to provide an<br>interface for Continuous Positive<br>Airway Pressure (CPAP) or Bi-<br>Level therapy. This mask is<br>intended for single-patient reuse<br>in the home and single-patient<br>reuse in the hospital / institutional<br>environment. This mask is to be<br>used on patients greater than 66<br>lbs (30 kg). | Substantially Equivalent.<br>The inclusion of "single-patient<br>reuse" is a narrower indication to<br>the "multi-patient, multi-use" in the<br>hospital / institutional environment<br>and does not alter the intended<br>use of the device. The device is<br>not approved for reprocessing<br>(cleaning and disinfecting<br>methods) in the clinical setting. | | Environment of Use | Home / Hospital | Home / Hospital | Identical | | Patient Population | Sleep Apnea Patients > 66 Ibs /<br>30 kg | Sleep Apnea Patients > 66 Ibs /<br>30 kg | Identical | | Availability | Prescription Use | Prescription Use | Identical | | Contraindications | None | None | Identical | | Product Code | BZD | BZD | Identical | | Anatomical Sites | Mask topically interfaces with<br>nose and skin on the face. | Mask topically interfaces with<br>nose and skin on the face. | Identical | | Sterile/Non-Sterile | Non-Sterile | Non-Sterile | Identical | | Therapy Pressure<br>Range | 4 - 20 cmH2O | 4 - 20 cmH2O | Identical | | Connecting Element | 22mm L-Shaped Swivel<br>Connector (Removable)<br>Polycarbonate | 22mm L-Shaped Swivel<br>Connector (Permanently<br>Secured)<br>Polycarbonate | Substantially Equivalent.<br>An identical 22mm L-Shaped<br>Swivel Connector is utilized in the<br>predicate and subject device. The<br>connector in the subject device is<br>permanently secured. | | Device Design<br>(Nasal Interface) | Soft Fabric Seal | Soft Fabric Seal | Substantially Equivalent.<br>The structure of the nasal<br>interface are similar in design and<br>materials. Verification and<br>validation testing was performed<br>and the subject device met all<br>predefined acceptance criteria.<br>Any new materials have been<br>assessed and tested for<br>biocompatibility. | | Device Design<br>(Mask Body) | Soft Fabric | Soft Fabric | Substantially Equivalent.<br>Mask Body geometry was<br>changed. Verification and<br>validation testing was performed<br>and the subject device met all<br>predefined acceptance criteria.<br>Materials utilized in the design are<br>identical. | | Feature | Predicate Device:<br>SleepWeaver élan (K120757) | Subject Device:<br>SleepWeaver 3D Nasal Mask | Comments | | Device Design<br>(Headgear) | 4-Point Adjustable Elastic Fabric | 4-Point Adjustable Elastic Fabric<br>(Addition of Integrated Plastic<br>Component) | Substantially Equivalent.<br>The "Integrated Plastic<br>Component" positions the lower<br>straps below the patient's ears.<br>Materials utilized in the design are<br>identical. | | Accessories | Feather Weight Tube & Tether<br>Strap | Feather Weight Tube & Tether<br>Strap | Identical<br>(Previously cleared under<br>K120757 and has not been<br>modified) | | Size (Mask) | Three (3) Sizes<br>(Small, Medium, Large) | One (1) Size | Substantially Equivalent.<br>The subject device has one size<br>of mask due to the nasal interface<br>design and material. Verification<br>and validation testing was<br>performed and the subject device<br>met all predefined acceptance<br>criteria. | | Size (Headgear) | One (1) Size | Two (2) Sizes<br>(Regular, Large) | Substantially Equivalent.<br>The subject device has two sizes<br>of headgear to accommodate a<br>broader range of use among the<br>patient population. Verification<br>and validation testing was<br>performed and the subject device<br>met all predefined acceptance<br>criteria. | # Table 1: Comparison Table of SleepWeaver 3D Nasal Mask and Predicate {7}------------------------------------------------ ## VII. PERFORMANCE DATA ### Non-Clinical Tests Extensive performance testing was conducted in accordance with ISO 17510:2015 and results were satisfactory to demonstrate substantial equivalence. Performance testing included: . Fixed Leak Rate (Acceptable per ISO 17510:2015) | Pressure (cmH2O) | 4 | 5 | 10 | 15 | 20 | |------------------|----|----|----|----|----| | Flow (LPM) | 18 | 21 | 32 | 41 | 50 | - Pressure Drop (Resistance to Flow) (@50LPM: 0.3cmH2O; @100LMP: 0.5cmH2O) . - CO2 Rebreathing (Acceptable per ISO 17510:2015) - Sound Pressure (Power Level: 26dBA; Pressure Level @ 1m: 18dBA) ● - Reliability (90 wash cycles without damage or loss of function) The SleepWeaver 3D Nasal Mask has been designed and tested to meet the requirements of the following standards: - 1. ISO 14971:2007 Medical Devices Application of Risk Management to Medical Devices - 2. ISO 17510:2015 Medical Devices -- Sleep Apnoea Breathing Therapy -- Masks and Application Accessories - 3. ISO 10993-1:2009 Biological Evaluation of Medical Devices Part 1: Evaluation And Testing within a Risk Management Process - 4. ISO 10993-5:2009 Biological Evaluation of Medical Devices Part 5: Tests for In Vitro Cytotoxicity - 5. ISO 10993-10:2010 Biological Evaluation of Medical Devices Part 10: Tests for Irritation and Skin Sensitization {8}------------------------------------------------ The skin contacting portion of the nasal interface material is new and was identified as direct patient contacting, permanent duration (> 30 days) and biocompatibility testing was conducted by applying the principles of biological evaluation of medical devices, in accordance with ISO 10993-1. All tests were successfully completed with acceptable results. Biocompatibility for all other materials utilized in the device is based on the previously cleared predicate device, the SleepWeaver élan Nasal CPAP (K120757). ### Clinical Tests Clinical tests were not required to demonstrate the substantial equivalence of the SleepWeaver 3D Nasal Mask. Product functionality has been adequately assessed by non-clinical tests. ## VIII. CONCLUSIONS Design verification and validation testing was performed on the SleepWeaver 3D Nasal Mask and the subject device met all predefined acceptance criteria. Circadiance has determined that the modifications do not raise different types of safety and effectiveness questions. In summary, the performance and technological characteristics of the SleepWeaver 3D Nasal Mask has been adequately assessed by nonclinical tests and is substantially equivalent to the predicate device, the SleepWeaver élan Nasal CPAP Mask (K120757).
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...